协同作用的microRNAs通过调节临床相关的点来抑制人类质母细胞瘤的进展
Silvia Rancati1, Rui C Pereira1, Michele Schlich2
1Neurobiology of miRNAs, Istituto Italiano di Tecnologia, 16163 Genoa, Italy.
Molecular therapy. Nucleic acids
|December 30, 2025
概括
这项研究表明,恢复微RNAs (miRNAs) 的组合有效地通过减少瘤生长,侵入性和化学抵抗性来对抗质母细胞瘤. 在临床前模型中,纳米配制的miRNAs显示出具有低毒性的治疗潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 质母细胞瘤 (GBM) 是一种具有耐治疗性质母细胞干细胞 (GSCs) 的侵袭性脑瘤.
- 微RNAs (miRNAs) 是致癌途径的关键调节者,但它们的瘤抑制作用通常会在GBM中消失.
- 需要一种多式疗法策略来克服GBM的耐药性和侵入性.
研究的目的:
- 为了研究恢复miRNAs对质母细胞瘤的组合的协同治疗效果.
- 评估miRNA恢复对GBM细胞生长,侵入性,干性和化学敏感性的影响.
- 在临床前的GBM模型中评估纳米配方miRNAs的疗效和毒性.
主要方法:
- 在干细胞允许条件下培养的患者衍生GBM细胞.
- 通过局部注射在正位异种移植小鼠模型中给药纳米配方miRNAs.
- 进行多组学和计算分析以确定受miRNA恢复影响的分子标和途径.
主要成果:
- miRNA恢复显著降低了GBM瘤的生长,侵入性和茎状.
- 联合miRNA疗法增强了GBM细胞对temozolomide (TMZ) 的敏感性.
- 在体内研究证实了纳米配方miRNAs的治疗疗效和低毒性.
- 发现miRNA抑制了细胞外矩阵相互作用,特别是原路径,并降低了GBM进展基因的调节.
结论:
- 结合式miRNA疗法代表了质母细胞瘤治疗的有前途的新战略.
- 已识别的miRNA及其向途径为GBM诊断和治疗提供了潜在的新分子标.
- 恢复抑制瘤的miRNA功能可以克服质母细胞瘤的治疗阻力.
相关概念视频
MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs
23.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K


